Reduced SLIT2 is associated with increased cell proliferation and arsenic trioxide resistance in acute promyelocytic leukemia (2020)
- Authors:
- USP affiliated authors: REGO, EDUARDO MAGALHÃES - FM ; WEINHÄUSER, ISABEL - FMRP ; MARTINS, DIEGO ANTONIO PEREIRA - FMRP ; SILVEIRA, DOUGLAS RAFAELE ALMEIDA - FM ; SIMÕES, LUÍSE ARAÚJO DE ALBUQUERQUE - FM ; BIANCO, THIAGO MANTELLO - FMRP
- Unidades: FM; FMRP
- DOI: 10.3390/cancers12113134
- Subjects: PROLIFERAÇÃO CELULAR; TIROXINA; ARSÊNIO; LEUCEMIA
- Keywords: ATRA; SLIT2; Acute promyelocytic leukemia; Treatment outcomes
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
WEINHÄUSER, Isabel et al. Reduced SLIT2 is associated with increased cell proliferation and arsenic trioxide resistance in acute promyelocytic leukemia. Cancers, v. 12, n. 11, p. 1-16, 2020Tradução . . Disponível em: https://doi.org/10.3390/cancers12113134. Acesso em: 27 dez. 2025. -
APA
Weinhäuser, I., Martins, D. A. P., Ortiz, C., Silveira, D. R. A., Simões, L. A. de A., Bianco, T. M., et al. (2020). Reduced SLIT2 is associated with increased cell proliferation and arsenic trioxide resistance in acute promyelocytic leukemia. Cancers, 12( 11), 1-16. doi:10.3390/cancers12113134 -
NLM
Weinhäuser I, Martins DAP, Ortiz C, Silveira DRA, Simões LA de A, Bianco TM, Araujo CL, Melo RAM, Bittencourt RI, Pagnano K, Rego EM. Reduced SLIT2 is associated with increased cell proliferation and arsenic trioxide resistance in acute promyelocytic leukemia [Internet]. Cancers. 2020 ; 12( 11): 1-16.[citado 2025 dez. 27 ] Available from: https://doi.org/10.3390/cancers12113134 -
Vancouver
Weinhäuser I, Martins DAP, Ortiz C, Silveira DRA, Simões LA de A, Bianco TM, Araujo CL, Melo RAM, Bittencourt RI, Pagnano K, Rego EM. Reduced SLIT2 is associated with increased cell proliferation and arsenic trioxide resistance in acute promyelocytic leukemia [Internet]. Cancers. 2020 ; 12( 11): 1-16.[citado 2025 dez. 27 ] Available from: https://doi.org/10.3390/cancers12113134 - Treatment with the recombinant SLIT2 protein delays AML leukemogenesis in vivo
- Association between ANXA2*5681 polymorphism (rs7170178) and osteonecrosis in haemoglobin SS-genotyped patients
- Association of KLOTHO polymorphisms with clinical complications of sickle cell anemia
- MLL5 improves ATRA driven differentiation and promotes xenotransplant engraftment in acute promyelocytic leukemia model
- Tumor associated macrophages promoted fatal patient derived acute promyelocytic leukemia in vivo
- Co-occurrence of DNMT3A, NPM1, FLT3 mutations identifies a subset of acute myeloid leukemia with adverse prognosis [Carta]
- Alpha thalassemia, but not βS-globin haplotypes, influence sickle cell anemia clinical outcome in a large, single-center Brazilian cohort
- Clinical Signicance of Mitochondrial DNA Content in Acute Promyelocytic Leukemi
- Association of HMIP1 C-893A polymorphism and disease severity in patients with sickle cell anemia
- Regulação das células-tronco hematopoéticas mediada pelas células Natural Killer em modelo de neoplasia mieloproliferativa
Informações sobre o DOI: 10.3390/cancers12113134 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003196730.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
